Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;52(1):73-80.
doi: 10.1007/s42770-020-00307-z. Epub 2020 May 31.

Antifungal resistance on Sporothrix species: an overview

Stefanie Bressan Waller  1 , Daiane Flores Dalla Lana  2 , Priscilla Maciel Quatrin  3 , Marcos Roberto Alves Ferreira  4 , Alexandre Meneghello Fuentefria  5 , Adelina Mezzari  5
Affiliations
Review

Antifungal resistance on Sporothrix species: an overview

Stefanie Bressan Waller et al. Braz J Microbiol. 2021 Mar.

Abstract

Introduction: The treatment of human and animal sporotrichosis is often performed with antifungal agents; however, the emergence of antifungal-resistant strains of Sporothrix species has been reported. We aimed to discuss the ability of Sporothrix species in developing resistance to the conventional antifungals and mechanisms for this.

Methodology: Published data on databases (PubMed, Science Direct, Google Scholar) were investigated using a combination of keywords from 2008 to 2019 by the StArt tool.

Results: The minimal inhibitory concentrations values based on the Clinical and Laboratory Standards Institute (CLSI) from eight references were classified according to the epidemiological cutoff values in wild-type or non-wild-type strains. In this way, non-wild-type S. schenckii and, mainly, S. brasiliensis isolates were recognized on itraconazole, amphotericin B, terbinafine, and voriconazole, which are strains that deserve more attention toward antifungal control, with a probable risk of mutation to antifungal resistance. Among the few reviewed studied on antifungal resistance, the melanin production capacity (DHN-melanin, L-DOPA melanin, and pyomelanin), the low genetic diversity due to the abnormal number of chromosomes, and the mutation in cytochrome P450 are some of the factors for developing resistance mechanism.

Conclusions: The emergence of Sporothrix species with in vitro antifungal resistance was evidenced and the possible mechanisms for resistance development may be due to the melanin production capacity, genetic diversity and mutations in cytochrome P450. Further studies should be carried out targeting gene expression for the development of antifungal resistance on Sporothrix species in order to prospect new therapeutic targets for human and veterinary use.

Keywords: Antifungal resistance; Gene expression; Genetic diversity; Melanin; Mutation; Sporothrix species; Sporotrichosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flowchart of research evidence and criteria for inclusion and exclusion of studies
See this image and copyright information in PMC

References

    1. Fischman Gompertz O, Rodrigues AM, Fernandes GF, Bentubo HD, de Camargo ZP, Petri V. Atypical clinical presentation of sporotrichosis caused by Sporothrix globosa resistant to itraconazole. Am J Trop Med Hyg. 2016;94:1218–1222. doi: 10.4269/ajtmh.15-0267. - DOI - PMC - PubMed
    1. Vettorato R, Heidrich D, Fraga F, Ribeiro AC, Pagani DM, Timotheo C, Amaro TG, Vettorato G, Scroferneker ML. Sporotrichosis by Sporothrix schenckii senso stricto with itraconazole resistance and terbinafine sensitivity observed in vitro and in vivo: case report. Med Mycol Case Rep. 2017;19:18–20. doi: 10.1016/j.mmcr.2017.10.001. - DOI - PMC - PubMed
    1. Espinel-Ingroff A, Abreu DPB, Almeida-Paes R, Brilhante RSN, Chakrabarti A, Chowdhary A, Hagen F, Córdoba S, Gonzalez GM, Govender NP, Guarro J, Johnson EM, Kidd SE, Pereira SA, Rodrigues AM, Rozental S, Szeszs MW, Ballesté Alaniz R, Bonifaz A, Bonfietti LX, Borba-Santos LP, Capilla J, Colombo AL, Dolande M, Isla MG, Melhem MSC, Mesa-Arango AC, Oliveira MME, Panizo MM, Pires de Camargo Z, Zancope-Oliveira RM, Meis JF, Turnidge J. International study of MIC/MEC distributions for definition of epidemiological cutoff values for Sporothrix species identified by molecular methods. Antimicrob Agents Chemother. 2017;61:e01057–e01017. doi: 10.1128/AAC.01057-17. - DOI - PMC - PubMed
    1. Guterres KA, de Matos CB, Osório Lda G, Schuch ID, Cleff MB. The use of (1-3) β-glucan along with itraconazole against canine refractory sporotrichosis. Mycopathologia. 2014;177:217–221. doi: 10.1007/s11046-014-9736-6. - DOI - PubMed
    1. Rodrigues AM, Della Terra PP, Gremião ID, Pereira SA, Orofino-Costa R, de Camargo ZP (2020) The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia 1–30. 10.1007/s11046-020-00425-0 - PubMed

LinkOut - more resources